ACTRN12617001544369CompletedPhase 4
Effect of pharmaceutical dopaminergic enhancement on performance in a complex optimisation task in healthy adults
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- The University of Melbourne
- Enrollment
- 32
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
- Allocation
- Randomised controlled trial
- Primary Purpose
- Treatment
- Masking
- Blinded (masking used)
Eligibility Criteria
- Ages
- 18 Years to 35 Years (—)
- Sex
- All
Inclusion Criteria
- •Healthy volunteers aged between 18 and 35 years old.
Exclusion Criteria
- •History of psychiatric or neurological illness including epilepsy, head injury, previous use of psychotropic medication, history of significant drug use, heart conditions (including high blood pressure, defined as above 140 mm/Hg systolic and/or 90 mm/Hg diastolic pressure as measured at the initial assessment session) pregnancy, or glaucoma. Any family history of sudden death of a first degree relative through cardiac or unknown causes before the age of 50 years old will also exclude the participant.
Investigators
Similar Trials
Active, not recruiting
Phase 1
REBOOT: Releasing the brakes on adult plasticityo medical condition is under investigation. The project investigates normal age-related decline in intellectual abilities.EUCTR2016-000891-54-SEAging Research Center, Karolinska Institutet and Stockholm University70
Completed
Phase 2
The effect of bromocriptine on endometrioma sizeIRCT20140802018655N6Shiraz University of Medical Sciences60
Recruiting
Phase 2
The effect of dopamine on the appropriate time of urination in oliguric patientsoliguria.Anuria and oliguriaIRCT2017011513366N6Vice Chancellor for Research,Arak University of Medical Sciences120
Completed
Phase 1
Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's DiseaseParkinson's DiseaseNCT00666653Oregon Health and Science University13
Completed
Not Applicable
The role of dopamine for positive treatment expectations and placebo analgesiapain perceptionhealthy subjectsDRKS00029366Klinische Neurowissenschaften und translationale Schmerzforschung, Universitätsmedizin Essen, Klinik für Neurologie169